
    
      This is an open-label study in patients diagnosed with ALF who are not responding to the
      institution's standards of care. Standard of care may include, but is not limited to,
      administration of N-acetylcysteine, lactulose, hypothermia therapy, and consideration for
      orthotopic liver transplant. Outcome measures are safety and decrease in ammonia levels.
    
  